Heidelberg, Germany

Thilo Oelert

This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Universitatsklinikum Heidelberg. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thilo Oelert. Retrieved from https://idiyas.com/inventor/thilo-oelert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thilo Oelert: Innovator in Immunosuppressive Blood Cell Technology

Introduction

Thilo Oelert is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of immunology, particularly in the development of methods for producing immunosuppressive blood cells. His work is particularly relevant for the treatment of autoimmune diseases, including multiple sclerosis, organ graft rejection, and graft-versus-host disease.

Latest Patents

Thilo Oelert holds a patent for "Immunosuppressive blood cells and methods of producing the same." This invention outlines a method for creating blood cells that can suppress immune responses, which is crucial for patients suffering from various autoimmune conditions. He has 1 patent to his name, showcasing his innovative approach to medical challenges.

Career Highlights

Throughout his career, Oelert has worked with prestigious institutions such as Universitätsklinikum Heidelberg and Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Thilo Oelert's notable coworkers include Peter Terness and Gerhard Opelz. Their collaborative efforts have further advanced the research and development of immunosuppressive therapies.

Conclusion

Thilo Oelert's work in immunosuppressive blood cell technology represents a significant advancement in the treatment of autoimmune diseases. His innovative methods and collaborations with esteemed colleagues highlight his commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…